Hetero Labs Limited (India) holds 151 active US FDA Type II Drug Master Files and 13 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 4 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Hetero Labs Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hetero-labs-limited

Overview

Hetero Labs Limited is a leading global pharmaceutical company based in India, specializing in the development, manufacturing, and distribution of generic pharmaceuticals. It is known for its expertise in antiretroviral drugs and a strong presence in both the domestic and international markets.

Core services & business areas

Active Pharmaceutical Ingredients (APIs)Finished DosagesRegulatory AffairsFormulation DevelopmentContract Manufacturing

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Hetero Labs Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Hetero Labs Limited holds 151 active (164 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • OLAPARIB (FORM-A)Active2026-04-22
  • AXITINIB (FORM-XLI)Active2025-11-05
  • LENACAPAVIR SPRAY-DRIED DISPERSIONActive2025-10-27
  • LENACAPAVIR SODIUMActive2025-10-27
  • VISMODEGIBActive2025-08-20
  • ASCIMINIB HYDROCHLORIDE PREMIXActive2025-07-29
  • AVACOPANActive2025-06-26
  • ABEMACICLIBActive2025-05-22
  • BELZUTIFAN PREMIXActive2025-05-20
  • BELUMOSUDIL MESYLATEActive2025-04-29
  • DASATINIB MONOHYDRATEActive2025-03-27
  • IVACAFTOR PREMIXActive2025-03-27
  • OPICAPONEActive2025-03-27
  • CRIZOTINIBActive2025-03-25
  • SOTORASIB (FORM-III)Active2025-03-03
  • CARFILZOMIBActive2025-02-24
  • APALUTAMIDE PREMIXActive2024-12-27
  • TRILACICLIB DIHYDROCHLORIDE DIHYDRATEActive2024-11-13
  • RELUGOLIX (FORM-1)Active2024-09-27
  • BEROTRALSTAT DIHYDROCHLORIDEActive2024-09-18
  • VERICIGUAT (FORM-I)Active2024-08-31
  • VENETOCLAXActive2024-07-26
  • BOSUTINIB MONOHYDRATEActive2024-05-09
  • LENVATINIB MESYLATEActive2024-04-30
  • TOLVAPTAN POVIDONE PREMIXActive2024-01-31
  • ALECTINIB HYDROCHLORIDEActive2024-01-30
  • TIPIRACIL HYDROCHLORIDEActive2023-11-20
  • NAPROXENActive2023-09-29
  • DAROLUTAMIDE PREMIXActive2023-05-02
  • NAPROXEN SODIUMActive2023-04-07
  • DORAVIRINE PREMIXActive2022-06-23
  • AFATINIB DIMALEATE (FORM A)Active2022-05-07
  • ELAGOLIX SODIUMActive2022-05-07
  • FOSTAMATINIB DISODIUM HEXAHYDRATEActive2022-02-04
  • MIDOSTAURINActive2021-12-25
  • APALUTAMIDEActive2021-11-24
  • ENZALUTAMIDEActive2021-10-21
  • SUNITINIB MALATEActive2021-09-01
  • ETRAVIRINE PREMIXActive2021-06-15
  • OLAPARIBActive2021-04-17
  • DARUNAVIR AMORPHOUS (PROCESS-II)Active2021-04-10
  • OSIMERTINIB MESYLATEActive2021-02-04
  • NINTEDANIB ESYLATEActive2021-01-30
  • ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE PELLETS (AS 20.94%W/W OF ESOMEPRAZOLE)Active2020-12-23
  • PEMETREXED DISODIUM 2.5 HYDRATEActive2020-07-17
  • OBETICHOLIC ACIDActive2019-11-13
  • BICTEGRAVIR SODIUMActive2019-07-17
  • EPLERENONEActive2019-05-20
  • RITONAVIR USPActive2019-05-18
  • EMTRICITABINE (PROCESS-II)Active2018-10-04

Showing the 50 most relevant of 164 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to Hetero Labs Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Hetero Labs Limited in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Hetero Labs Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.